The application of electronic records and data analysis for good cold chain management practices

American Pharmaceutical Outsourcing

Volumn 7, Issue 3, 2006, Pages 56-61

  Bishara, Rafik ^a  

^a Parenteral Drug Association (PDA)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER PROGRAM; DATA ANALYSIS; DEVICE; DOCUMENTATION; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG QUALITY; ELECTRONICS; GOOD MANUFACTURING PRACTICE; HUMIDITY; INFORMATION PROCESSING; PROCESS MONITORING; QUALITY CONTROL; REVIEW; TEMPERATURE SENSITIVITY; TIME;

EID: 47349092232     PISSN: 15296318     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. "2004 Industry Profile and Healthcare Factbook", Table 281, "Estimated World Pharmaceutical Market by Market Share: 2003" Page 114, Healthcare Distribution Management Association (HDMA).
2. "Biopharmaceuticals, Current Market Dynamics and Future Outlook", pp. 7, 9, 15, and 48, ASInsights Nov. 2003, www.asiinsights.com.
3. "FDA Information Regarding Safety of Food and Biological Products", Distributed via the HAN Info Service, September 2003.
4. Good Distribution Practices (GDP). Working Document QAS/04.68 (RESTRICTED), World Health Organization, Geneva, 2004.
5. International Conference on Harmonization (ICH) Q1A: Stability Testing of New Drug Substances and Products, 2nd Revision, November 2003, originally published in 1994.
6. Draft Guidance for Industry, Stability Testing of Drug Substances and Drug Products. United States Food and Drug Administration, 1998.
7. Lucas, T. I., Bishara, R. H., and Seevers, R. H., "A Stability Program for the Distribution of Drug Products," Pharmaceutical Technology, July 2004, pp. 68-73.
8. Okeke, C. C., Bailey, L. C., Medwick, T., and Grady, L. T., "Temperature Fluctuations During Mail Order Shipment of Pharmaceutical Articles Using Mean Kinetic Temperature Approach," Pharmacopeial Forum, 23(3) May-June 1997, pp. 4155-4182.
9. Okeke, C. C., Bailey, L. C., Lindauer, R. F. Medwick, T., and Grady, L. T., "Evaluation of the Physical and Chemical Stability of Some Drugs when Exposed to Temperature Fluctuations During Shipment," Pharmacopeial Forum, 24(5) Sept-Oct 1998, pp. 7064-7073.
10. Okeke, C. C., Bailey, L. C., Medwick, T., and Grady, L. T., "Temperature and Humidity Conditions During Shipment in International Commerce," Pharmacopeial Forum, 25(2) Mar-April 1999, pp. 7949-7959.
11. Okeke, C. C., Watkins, J. W. III, Williams, W., Medwick, T., Bailey, L. C., and Grady, L. T., "A Study of the Temperature and Humidity Variations in the Shipping and Distribution of Anthrax Vaccines," Pharmacopeial Forum 26(3) May-June 2000, pp. 865-882.
12. General Chapter 〈1079〉 Good Storage and Shipping Practices, USP 28, Suppl. 2, (August 1, 2005).
13. Guidelines for Temperature Control of Drug Products during Storage and Transportation - (GUIDE-0069), Health Canada, October, 2005.
14. Guidelines on Good Distribution Practice of Medicinal Product for Human Use, (94/C63/03), European Union, 1994.
15. Guide to Control and Monitoring of Storage and Transportation Temperature Conditions for Medicinal Products and Active Substances, Irish Medicines Board, March 2006.
16. Australian Code of Good Wholesaling Practice for Therapeutic Goods for Human Use. Therapeutic Goods Administration, Commonwealth Department of Health, Housing and Community Services, November, 1991.
17. Thermal Performance of Refrigerated Transport Equipment - Specification and Testing, AS 4982-2003, Standards Australia.
18. Norms for the Good Distribution Practices of Medicines, Resolution by means of which the Good Distribution Practices of Medicines is Issued, Ministry of Health and Social Development, No. 253, Bolivarian Republic of Venezuela, June 2004.
19. National Sanitary Surveillance Agency, resolution-RCD234, August 17, 2005, 3rd Article, Paragraph 5-7 and 7th Article, Paragraph 2, Brazilian Official Gazette, August 26, 2005
20. Good Wholesaling Practice for Wholesalers, Distributors, and Bonded Warehouses, Medicines Control Council, Department of Health, Republic of South Africa, June 2003.
21. Bishara, R. H., and PSD Project Team, "Drug Product Distribution Chain," Stimuli to the Revision Process. USP Pharmacopeial Forum, Volume 29 (3), May-June 2003, pp. 864-875.
22. General Chapter 〈1118〉 Monitoring Devices - Time, Temperature, and Humidity, USP 29.
23. Seevers, R. H., Bishara, R. H., Harber, P. J., and Lucas T. I.: Designing Stability Studies for Time-Temperature Exposure. American Pharmaceutical Outsourcing, Volume 6 (5) pp. 18, 20, 21, 23, 55 (2005).
24. Bishara, R. H., Chair, Pharmaceutical Cold Chain Discussion Group, Parenteral Drug Association: Cold Chain Guidance for Medicinal Product: Maintaining the Quality of Temperature-Sensitive Medicinal Products through the Transportation Environment. Technical Report No. 39. PDA Journal of Pharmaceutical Science and Technology, September- October 2005, Supplement Vol. 59, No. S3.
25. Henderson, D., "FDA Asking $22m in User Fees, Even Some Affected Firms See Promise of Faster Action", The Boston Globe, Section: Business, Technology, Biotechnology, February 20, 2006.
26. Ames H., Sensitech, Inc. Internal Document, (Critical Component Reference).
27. Information extracted from the FDA website http://www.cfsan.fda.gov/~dms/ gmp-ape.html.